Activation of MAPK and NF-κB converges on inflammatory mediators and tumor-promoting genes such as IL1B, which facilitate tumor initiation, fibroblast activation, angiogenesis, EMT, and immune suppression (54–58). This evidence concerns the gene NFKB1 and neoplasm.